###begin article-title 0
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
Generation and Initial Characterization of FDD Knock In Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: LD. Performed the experiments: LG SM RV. Analyzed the data: LG RV LD. Wrote the paper: RV LD.
###end p 1
###begin p 2
Current address: The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research, North Shore - LIJ, Manhasset, New York, United States of America
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 46 49 46 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Deleersnijder1">[1]</xref>
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 69 72 69 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal2">[3]</xref>
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Kim1">[4]</xref>
###xml 583 584 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 699 702 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda1">[5]</xref>
###xml 704 707 701 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda2">[6]</xref>
###xml 709 712 706 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Fotinopoulou1">[7]</xref>
###xml 769 770 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Mutations in the integral membrane protein 2B [1], also known as BRI2[2], a type II trans-membrane domain protein cause two autosomal dominant neurodegenerative diseases, Familial British and Danish Dementia [3]. In these conditions, accumulation of a C-terminal peptide (ABri and ADan) cleaved off from the mutated precursor protein by the pro-protein convertase furin [4], leads to amyloid deposition in the walls of blood vessels and parenchyma of the brain. Recent advances in the understanding of the generation of amyloid in Alzheimer's disease has lead to the finding that BRI2 interacts with the Amyloid Precursor Protein (APP), decreasing the efficiency of APP processing to generate Abeta [5], [6], [7]. The interaction between the two precursors, APP and BRI2, and possibly between Abeta and ABri or ADan, could be important in influencing the rate of amyloid production or the tendency of these peptides to aggregate.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 155 157 155 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 57 63 <span type="species:ncbi:10090">murine</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
We have generated the first BRI2 Danish Knock-In (FDDKI) murine model of FDD, expressing the pathogenic decamer duplication in exon 6 of the BRI2 gene. FDDKI mice do not show any evident abnormal phenotype, with normal brain histology and no detectable amyloid deposition in blood vessel walls or parenchyma.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
###xml 103 104 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 9 15 <span type="species:ncbi:10090">murine</span>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
This new murine mouse model will be important to further understand the interaction between APP and BRI2, and to provide insights into the molecular basis of FDD.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI</italic>
###xml 170 171 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>1</sub></italic>
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>3</sub></italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITM2A</italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITM2B</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITM2C</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E25A</italic>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E25B</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E25C</italic>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Deleersnijder1">[1]</xref>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal2">[3]</xref>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Pittois1">[8]</xref>
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal3">[9]</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-SanchezPulido1">[10]</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 159 165 <span type="species:ncbi:9606">humans</span>
BRI2 is a type II trans-membrane protein of unknown function. The BRI gene belongs to a multigene family comprising at least three homologues in both mice and humans, BRI1, BRI2 and BRI3 (also referred to as ITM2A, ITM2B and ITM2C, or E25A, E25B and E25C, respectively) [1], [2], [3], [8], [9]. It possesses a BRICHOS domain, a conserved motif common to members of the BRI, ChM-I, SP-C and CA11 protein families, thought to have a role in the targeting of the respective proteins to the secretory pathway or to intracellular processing [10]. Proteins sharing the BRICHOS motif are dissimilar, and associate with a diverse range of phenotypes, varying from dementia to cancer and respiratory distress.
###end p 10
###begin p 11
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 72 75 72 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
###xml 296 297 296 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Plant1">[11]</xref>
###xml 812 813 812 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 813 816 813 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal2">[3]</xref>
###xml 907 910 907 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal2">[3]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Holton1">[12]</xref>
###xml 1466 1469 1466 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal2">[3]</xref>
###xml 1471 1475 1471 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Holton1">[12]</xref>
###xml 951 959 <span type="species:ncbi:9606">patients</span>
BRI2 was first described in relation to Familial British Dementia (FBD) [2], an autosomal dominant neurodegenerative disease characterized by the early onset of personality changes, memory and cognitive deficits, spastic rigidity and ataxia. In FBD, a C-terminal 34 amino acid (aa) peptide of BRI2 accumulates as amyloid, leading to severe amyloid angiopathy of the brain and spinal cord with perivascular amyloid plaque formation, parenchymal plaques affecting the limbic areas, cerebellum, cerebral cortex, neurofibrillary tangles of hippocampal neurons and periventricular white matter changes [11]. Familial Danish Dementia (FDD), previously known as heredopathia ophthalmo-otoencephalica, is an autosomal dominant disease characterized by the accumulation of an amyloidogenic C-terminal 34 aa peptide of BRI2[3]. FDD is characterized by early onset cataracts, deafness, progressive ataxia and dementia [3], [12]. Neuropathological examination of patients with FDD shows diffuse brain atrophy with a particularly severe involvement of the cerebellum, cerebral cortex and white matter, as well as the presence of very thin and almost demyelinated cranial nerves, and widespread amyloid angiopathy in the small blood vessels and capillaries of the cerebrum, choroid plexus, cerebellum, spinal cord and retina. In FDD, parenchymal compact plaques are consistently absent, whereas neurofibrillary tangles (NFTs) are the major histological finding in the hippocampus [3], [12].
###end p 11
###begin p 12
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Pittois1">[8]</xref>
###xml 297 298 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 382 388 382 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ABri</sub>
###xml 434 437 434 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
###xml 496 497 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 597 603 597 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
###xml 605 608 605 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal2">[3]</xref>
###xml 784 787 784 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
BRI2 is physiologically cleaved, at the C-terminus, by furin, a calcium-dependent serine endoprotease, producing a 23 aa soluble C-terminal fragment. FBD and FDD are due to mutations in the BRI2 gene located on chromosome 13q14 [2], [8]. In FBD, a single base substitution at the stop codon of BRI2 generates a longer open reading frame, resulting in a larger, 277 aa precursor (BRI2-ABri, compared to the 266 aa long normal protein) [2]. In FDD, a decamer duplication in the 3' region of the BRI2 gene, right before the stop codon, leads as well to the production of a longer, 277 aa protein (BRI2-ADan) [3]. The genetic defect is different, but the outcome is the same: the generation of a longer 34 aa C-terminal fragment, ABri in FBD and ADan in FDD, which accumulates as amyloid [2].
###end p 12
###begin p 13
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Holton1">[12]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Holton2">[13]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Rostagno1">[14]</xref>
###xml 516 520 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Holton1">[12]</xref>
###xml 561 564 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal1">[2]</xref>
###xml 566 570 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Holton1">[12]</xref>
###xml 572 576 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Tomidokoro1">[15]</xref>
Several neuropathological features are common to FBD, FDD and Alzheimer's disease (AD): amyloid deposition and neurodegeneration in the central nervous system (CNS), accumulation of complement proteins and their pro-inflammatory activation products, including iC3b, C4d, Bb, and C5b-9, neurofibrillary pathology and hyperphosphorylated tau [12], [13], [14]. Furthermore, in FDD, Alzheimer's Abeta co-deposits with ADan, mainly in vascular and perivascular amyloid lesions and less in parenchymal preamyloid deposits [12], while compact plaques are not frequent [2], [12], [15].
###end p 13
###begin p 14
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 91 92 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 201 204 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda1">[5]</xref>
###xml 206 209 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda2">[6]</xref>
###xml 211 214 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Fotinopoulou1">[7]</xref>
###xml 298 299 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 597 600 583 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda1">[5]</xref>
###xml 605 606 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 667 668 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 800 804 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda3">[16]</xref>
###xml 847 848 833 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 944 948 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda4">[17]</xref>
###xml 981 982 960 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1033 1034 1012 1013 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1104 1108 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Kim2">[18]</xref>
More recently, a new link between BRI2 and Abeta has been found. It has been shown that BRI2 binds APP in a region comprising the extracellular juxtamembrane domains of both proteins, in a cis fashion [5], [6], [7]. This interaction leads to interference on the physiological processing of APP: BRI2 restricts the docking of gamma-secretase to APP and the access of alpha- and beta-secretases to their cleavage site on APP itself. The overall result of this interaction is the reduction of the amyloidogenic processing of APP, without a direct inhibition of the general activity of the secretases [5]. BRI2 maturation is required for this function. In fact, only mBRI2 (and not the immature precursor) binds mature APP and inhibits its processing on the plasma membrane and in endocytic compartments [16]. Matsuda et al have further shown that BRI3, a member of the BRI family, binds and inhibit the action of alpha- and beta-secretases on APP [17]. Others have argued that the BRI2-23 wild type C-terminal peptide, released from BRI2 by furin/furin-like cleavage, can inhibit Abeta aggregation in vitro [18].
###end p 14
###begin p 15
###xml 191 192 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Pickford1">[19]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 520 521 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 1522 1523 1522 1523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1629 1631 1629 1631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 273 288 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 751 756 <span type="species:ncbi:9606">human</span>
###xml 808 813 <span type="species:ncbi:10090">mouse</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 1254 1259 <span type="species:ncbi:9606">human</span>
###xml 1491 1496 <span type="species:ncbi:9606">human</span>
###xml 1513 1518 <span type="species:ncbi:10090">mouse</span>
###xml 1605 1611 <span type="species:ncbi:10090">murine</span>
The interaction between these two amyloidogenic proteins can be of interest, especially for the design of new therapeutic strategies for AD and FBD/FDD. To this end, the processing of the BRI2 precursor, both in the wild type allele and its mutant form must be understood. Transgenic mice bearing the British or Danish mutations have been generated, and are under investigation as models of dementias and cerebral amyloid angiopathies [19], [20]. A transgenic FDD model which over-expresses the Danish mutant form of BRI2 shows amyloid deposition in the walls of blood vessels of the cerebrum and cerebellum, parenchymal amyloid deposition and reactive gliosis, ADan amyloidosis and some signs of cerebellar ataxia [20]. Transgenic over-expression of human mutant genes has been extensively used to generate mouse models for human neurodegenerative disorders due to the need of over-expressing enough amount of the mutant protein in order to observe a phenotype. It is however possible that some disorders may, at least partially, be due to loss of function rather than a gain of toxic function due to mutations. If this were the case, a transgenic approach would be counterproductive. Therefore, we have reasoned that models reproducing the genetics of human pathologies may be worth studying since they may unveil important disease mechanisms that a transgenic approach may miss or, possibly, hide. Thus, we have generated a genetically faithful model of FDD by introducing the pathogenic human mutation in the mouse BRI2 gene by a knock-in technology. Here, we describe the generation of this Knock-In murine model of FDD (FDDKI) and its initial characterization.
###end p 15
###begin title 16
Materials and Methods
###end title 16
###begin title 17
Ethics Statement
###end title 17
###begin p 18
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 84 88 <span type="species:ncbi:10090">Mice</span>
Mice were maintained on a C57BL/6 background for several generations (at least 15). Mice were handled according to the Ethical Guidelines for Treatment of Laboratory Animals of Albert Einstein College of Medicine. The procedures were described and approved in animal protocol number 20040707.
###end p 18
###begin title 19
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 6 10 <span type="species:ncbi:10090">Mice</span>
FDDKI Mice Construction
###end title 19
###begin p 20
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
To clone the ADan mutation allele, a fragment obtained form BAC (containing mouse BRI2 genome) was amplified by PCR with the following primers:
###end p 20
###begin p 21
###xml 4 43 4 43 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-cccAAGCTTtttttttttttttttaaagacaac-3&#8242;</named-content>
###xml 50 83 50 83 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-gggAAGCTTgaagtggtcagcagggag-3&#8242;</named-content>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 220 221 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 334 342 334 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">template</italic>
Fw: 5'-cccAAGCTTtttttttttttttttaaagacaac-3'; Rev: 5'-gggAAGCTTgaagtggtcagcagggag-3', obtaining a 7536 bp fragment, flanked by 2 HindIII sites, and comprising part of Intron 2 to a 3'UTR region, up to 3850 bp from the BRI2 stop codon. Such a fragment was cloned into a pBS vector, into HindIII sites (pBS-Ex3-6 HindIII), and used as a template for subsequent cloning.
###end p 21
###begin p 22
###xml 158 160 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 223 230 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 305 311 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HincII</italic>
###xml 321 326 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI</italic>
###xml 355 361 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HincII</italic>
###xml 367 372 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI</italic>
###xml 396 400 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SmaI</italic>
###xml 405 410 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI</italic>
A 340 bp fragment containing the ADan (duplication 786-795 of cDNA) mutation, plus a humanizing substitution a-->g (acc-->gcc = Threonine-->Alanine) at the 12th codon of exon 6, was obtained by serial PCRs, using pBS-Ex3-6 HindIII as a template. The final external primers contained restriction sites for HincII (5') and EcoRI (3'). The mutated fragment (HincII-ADan-EcoRI) was inserted into the SmaI and EcoRI sites of a pBS vector yielding pBS-ADan0.3.
###end p 22
###begin p 23
###xml 16 27 16 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI-EcoRI</italic>
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI-XhoI</italic>
Subsequently, 2 EcoRI-EcoRI and EcoRI-XhoI fragments (2.6 kbp total) were cut from the template and added 3', in tandem, to pBS-ADan0.3, generating pBS-ADan2.9, containing the Right Arm (RA) fragment of the construct.
###end p 23
###begin p 24
###xml 2 11 2 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NotI-XhoI</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NotI</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SacII</italic>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SacII</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XhoI</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XhoI</italic>
A NotI-XhoI fragment from pBS-ADan2.9, comprising the RA, was inserted into NotI and SacII sites of a Soriano PGK-Neo-dTA vector (blunt-ended by the SacII and XhoI digestion followed by treatment of T4-exonuclease and Klenow polymerase respectively) at 5'of the Neo cassette. The XhoI site was reconstituted upon ligation of the fragment into the vector.
###end p 24
###begin p 25
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HincII</italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HincII</italic>
The construct's Left Arm was extracted from the template with EcoRI and HincII, generating a 1.1 kbp into Intron 5 up to the corresponding HincII site, 5' of Exon 6 (start of Right Arm). The fragment was thus inserted into the PGK-Neo-dTA vector at 3' of the Neo cassette and 5' of the dTA cassette.
###end p 25
###begin p 26
The resulting construct was thus:
###end p 26
###begin p 27
---Right Arm-LoxP1-PGK-Neomycin cassette-LoxP2-Left Arm-dTA cassette---.
###end p 27
###begin p 28
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SalI</italic>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Wakayama1">[21]</xref>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The resulting construct was linearized with SalI and purified prior to injection in ES cells strain 129 by electroporation. ES culture was performed on feeder layer, and further electroporation and handling was also performed according to the methodology employed at Dept of Cell Biology, Albert Einstein College of Medicine, and according to Wakayama et al. [21]. In particular, after electroporation, ES cells were re-plated in 55 cm2 dishes and let grow until visible clones would appear. Clones were then picked and transferred to 96 well plates in triplicates. Triplicates were either screened by PCR or frozen for subsequent use and further analysis.
###end p 28
###begin p 29
Homologous recombinants were selected with G418 (200 microg/ml) and dTA exclusion.
###end p 29
###begin p 30
Injection of the two Danish ES cell clones into C57BL/6J blastocysts was performed at the Albert Einstein College of Medicine gene-targeting facility, according to the current facility protocol ().
###end p 30
###begin title 31
PCR Analysis
###end title 31
###begin p 32
###xml 197 201 <span type="species:ncbi:10090">mice</span>
The PCR screening was performed using the Expand Long Template PCR System (Roche-applied-Science) with Betaine, according to the manufacturer instructions. PCR analysis of recombinant ES cells and mice was conducted with the following primers and digestion strategies to identify the correct recombinant clones and strains:
###end p 32
###begin p 33
ES cells:
###end p 33
###begin p 34
Left arm:
###end p 34
###begin p 35
###xml 16 46 16 46 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGTCCTACCTTATCCATGAGCAC-3&#8242;</named-content>
Genomic primer: 5'-CAGTCCTACCTTATCCATGAGCAC-3'
###end p 35
###begin p 36
###xml 21 50 21 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTTCCTCGTGCTTTACGGTATC-3&#8242;</named-content>
Neo cassette primer: 5'- CTTCCTCGTGCTTTACGGTATC-3'
###end p 36
###begin p 37
Product: 1637 bp
###end p 37
###begin p 38
Right arm:
###end p 38
###begin p 39
###xml 16 47 16 47 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AGTCTGTATCTCACTACGGCATCC-3&#8242;</named-content>
Genomic primer: 5'- AGTCTGTATCTCACTACGGCATCC-3'
###end p 39
###begin p 40
###xml 21 50 21 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TGCACGAGACTAGTGAGACGTG-3&#8242;</named-content>
Neo cassette primer: 5'- TGCACGAGACTAGTGAGACGTG-3'
###end p 40
###begin p 41
Product: 3403 bp
###end p 41
###begin p 42
Amplification of the inserted construct and digestion:
###end p 42
###begin p 43
###xml 25 55 25 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGTCCTACCTTATCCATGAGCAC-3&#8242;</named-content>
Genomic upstream primer: 5'-CAGTCCTACCTTATCCATGAGCAC-3'
###end p 43
###begin p 44
###xml 27 57 27 57 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTCTGTATCTCACTACGGCATCC-3&#8242;</named-content>
Genomic downstream primer: 5'-AGTCTGTATCTCACTACGGCATCC-3'
###end p 44
###begin p 45
Product: 4300 bp = construct without Neo cassette; NotI digestion-->2900 bp + 1300 bp
###end p 45
###begin p 46
Product: 6109 bp = construct with Neo cassette; NotI digestion-->3100 bp + 2900 bp
###end p 46
###begin p 47
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice:
###end p 47
###begin p 48
Whole construct
###end p 48
###begin p 49
Set 1
###end p 49
###begin p 50
###xml 11 37 11 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGGCACCACCCACAATAGG-3&#8242;</named-content>
Fw primer: 5'-ATGGCACCACCCACAATAGG-3'
###end p 50
###begin p 51
###xml 12 39 12 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTAGCAACTGGTAACAGTGC-3&#8242;</named-content>
Rev primer: 5'-CCTAGCAACTGGTAACAGTGC-3'
###end p 51
###begin p 52
Product: 2027 bp with Neo cassette
###end p 52
###begin p 53
Product: 332 bp without Neo cassette
###end p 53
###begin p 54
Product: 194 bp wild type
###end p 54
###begin p 55
Set2
###end p 55
###begin p 56
###xml 11 37 11 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGGCACCACCCACAATAGG-3&#8242;</named-content>
Fw primer: 5'-ATGGCACCACCCACAATAGG-3'
###end p 56
###begin p 57
###xml 12 39 12 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ggtaagctctaaggagaagcg-3&#8242;</named-content>
Rev primer: 5'-ggtaagctctaaggagaagcg-3'
###end p 57
###begin p 58
Product: 2500 bp with Neo cassette
###end p 58
###begin p 59
Product: 849 bp without Neo cassette
###end p 59
###begin p 60
Product: 704 bp wild type
###end p 60
###begin p 61
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Due to the specific sequences present in the amplified PCR product, no digestion of the amplicon could be performed on the mice PCR analysis. PCR products were thus sequenced to ascertain that the targeted sequence was correctly inserted in the genomic DNA. The sequence has been deposited in GenBank (accession number GQ424832).
###end p 61
###begin title 62
Southern Blot Analysis
###end title 62
###begin p 63
###xml 47 52 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
Twenty microg of genomic DNA was digested with BamHI overnight, run on a 1% TAE agarose gel and transferred on a Hybond-N+ membrane (Amersham).
###end p 63
###begin p 64
The probe was prepared by PCR from a BAC clone (RP24) with the following primers:
###end p 64
###begin p 65
-Left arm:
###end p 65
###begin p 66
###xml 4 31 4 31 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GACAGAGGTTCTGCCCTCAG-3&#8242;</named-content>
Fw: 5'- GACAGAGGTTCTGCCCTCAG-3'
###end p 66
###begin p 67
###xml 5 30 5 30 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCGAGTCGTAGGACAGTG-3&#8242;</named-content>
Rev: 5'-ACCGAGTCGTAGGACAGTG-3'
###end p 67
###begin p 68
Probe size: 547 bp
###end p 68
###begin p 69
-Right arm:
###end p 69
###begin p 70
###xml 4 33 4 33 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTGTGCTGCCTGACACTACTTC-3&#8242;</named-content>
Fw: 5'- CTGTGCTGCCTGACACTACTTC-3'
###end p 70
###begin p 71
###xml 5 34 5 34 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TCTGTCCATACTCCCTGTCCTT-3&#8242;</named-content>
Rev: 5'- TCTGTCCATACTCCCTGTCCTT-3'
###end p 71
###begin p 72
Probe size: 515 bp.
###end p 72
###begin p 73
###xml 54 56 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
One microg of PCR probe was labelled with 5 microL of 32P-dCTP (3000 Ci/mmol, ICN) and purified through a Push Column (Stratagene) according to the manufacturer's protocol. Membranes, containing the cleaved genomic DNA, were hybridized at 65degreesC and subsequently washed 4 times in SSC buffer (Sigma). Film was exposed to the hybridised membranes at -80degreesC and then developed.
###end p 73
###begin title 74
General Pathology Analysis
###end title 74
###begin p 75
###xml 17 19 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
Wild-type and FDDKI animals were studied at 18 months of age. After anesthesia, animals were perfusion-fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) (Sigma), after which brains and organs were removed, embedded in paraffin and sectioned. Eight microm sections were cut and mounted on poly-l-lysine-coated slides. After deparaffinization in Xylene ad rehydration, sections were stained with hematoxylin and eosin (H&E), Congo red standard methods. Mineralization was visualized in H&E sections as a deep basophilic amorphous and/or granular material.
###end p 75
###begin title 76
Brain Histology and Immunohistochemistry
###end title 76
###begin p 77
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 464 468 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 682 686 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 966 970 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
Wild-type, FDDKI and FDD-Tg animals were studied at 18 months of age. After anesthesia, animals were perfusion-fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) (Sigma), after which brains were removed, embedded in paraffin and sectioned. Eight microm sections were cut and mounted on poly-l-lysine-coated slides. Sections were stained with H&E, Congo red and Thioflavin S (ThS) methods. Immunohistochemical stainings were carried out as described [20] with following primary antibodies: glial fibrillary acidic protein (GFAP) (Dako, Carpinteria, CA); ubiquitin (Dako); amyloid beta protein (Abeta) clone 4G8 (SIGNET, Dedham, MA); and ADan amyloid peptide (Ab 1700) [20]. Immunostaining was visualized using the avidin-biotin system (Vectastain; Vector Laboratories, Burlingame, CA) and 3,3'-diaminobenzidine (Sigma) as the chromogen. The sections were counterstained with cresyl violet or H&E. ADan transgenic (FDD-Tg) mice were described elsewhere [20].
###end p 77
###begin title 78
Neuronal Cultures
###end title 78
###begin p 79
###xml 24 26 24 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Giliberto1">[22]</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Giliberto2">[23]</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Neuronal cultures of FDDKI mice, and wt littermates, were performed as described previously [22], [23] from E16-17 fetuses.
###end p 79
###begin title 80
Western Blot
###end title 80
###begin p 81
###xml 85 87 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Matsuda1">[5]</xref>
###xml 549 550 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 630 631 630 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Akiyama1">[24]</xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Western blot was conducted on protein extracts from brains or neuronal culture of FDDKI mice and wt littermates, as described previously [5] for cells lysates and brain tissue. Briefly, primary neuronal cells were lysed in Hepes-Triton buffer (20 mM Hepes/NaOH pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.5% Triton X-100, plus protease inhibitors (PIs)) on ice for 30 min. The lysates were cleared by spinning at 20,000 g for 10 min. Equal amount of proteins of cleared lysates were loaded on SDS-PAGE and transfered onto nitrocellulose membranes; APP and BRI2 (wild type and Danish mutants) were detected by 22C11 (Chemicon, MAB348) or BRI2 antibody, generously provided by Dr. Haruhiko Akiyama, respectively [24].
###end p 81
###begin title 82
Results
###end title 82
###begin title 83
###xml 38 40 38 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 41 45 <span type="species:ncbi:10090">Mice</span>
Generation and Characterization of FDDKI Mice
###end title 83
###begin p 84
###xml 66 68 66 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 109 110 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK-neo</italic>
###xml 369 375 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK-dt</italic>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 459 460 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 621 622 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 687 694 687 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g001">Fig. 1a</xref>
###xml 713 714 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
###xml 703 709 <span type="species:ncbi:10090">murine</span>
The targeting strategy for the generation of the Danish mutant FDDKI mice entailed the replacement of the BRI2 exon 6 with a mutated exon 6 carrying the FDD mutation. We generated a targeting vector for the introduction of FDD BRI2 mutation. The vector used the floxed PGK-neo selection cassette and contains a 5' homologous region and the negative selection cassette, PGK-dt. The 3' homologous region introduced the FDD mutation and a BamHI site into the BRI2 mouse gene. The 10 nucleotide insertion found in patients with FDD was introduced before the stop codon. In order to humanize the mouse C-terminal region of BRI2, an alanine (A) was substituted for threonine (T) at codon 250 (Fig. 1a) of the murine BRI2 gene.
###end p 84
###begin title 85
###xml 17 19 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Generation of FDDKI mice.
###end title 85
###begin p 86
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
1a. Schematic representation of the construct that was injected in 129 ES cells, showing site of ADan mutation on Exon 6, primer sites, site of Southern Blot probe, LoxP, pgk-dt and pgk-Neo sites. The bottom graphics depict the construct with and without the pgk-Neo cassette that has been removed by means of Cre recombinase. 1b. Examples of 2 ES clones positive for the homologous recombination of the mutated allele: left arm (a-c: 1.67 kb) and right arm (b-d: 3.4 kb) PCRs are shown. 1c. Southern Blot showing a shift from the 11.9 kb of the wild type genome to the 8.9 kb band of the FDD KI mice, due to the insertion of a new BamHI site. KI mice show both bands, indicating heterozygosity.
###end p 86
###begin p 87
###xml 171 178 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK-neo</italic>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK-dt</italic>
The linearized targeting vector was transfected into 129 ES cells by electroporation. In the presence of the positive selection drug, G418, only those clones in which the PGK-neo selection cassette was integrated and the PGK-dt cassette was removed by homologous recombination would survive. ES cell clones carrying the targeting vector by random, non-homologous integration, were eliminated due to expression of diphtheria toxin.
###end p 87
###begin p 88
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tADan</italic>
###xml 543 544 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 540 544 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 582 583 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 583 590 571 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tADan/+</sup>
###xml 583 590 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>tADan/+</sup></italic>
###xml 601 602 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 602 609 590 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tADan/+</sup>
###xml 602 609 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>tADan/+</sup></italic>
###xml 631 632 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 632 639 620 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tADan/+</sup>
###xml 632 639 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>tADan/+</sup></italic>
###xml 667 674 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g001">Fig. 1b</xref>
###xml 735 755 723 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Material and Methods</xref>
After selection in G418-containing medium, ES cell clones carrying the proper homologous recombination and the tADan (targeted ADan) allele were identified by PCR for 5' region (i.e. Left Arm: if homologous recombination had occurred these primers would amplify a product of 1.67 kb) and for the 3' region (i.e. Right Arm: if homologous recombination had occurred these primers would amplify a product of 3.4 kb). Out of the approximately600 screened ES clones, we found three clones in which the Danish mutation was inserted in one of the BRI2 alleles. Representative positive (BRI2tADan/+344 and BRI2tADan/+339) and negative (BRI2tADan/+342) ES clones are shown in Fig. 1b. Also, PCR amplification and digestion, as specified in the Material and Methods section, was used to check the proper insertion of the construct in the genomic DNA and the removal of the Neo cassette (not shown).
###end p 88
###begin p 89
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g001">Fig. 1c</xref>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 179 172 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tADan/+</sup>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>tADan/+</sup></italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 501 506 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 548 553 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 567 574 543 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK-neo</italic>
###xml 608 609 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 609 615 585 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/+</sup>
###xml 609 615 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ADan/+</sup></italic>
###xml 626 627 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 627 633 603 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/+</sup>
###xml 627 633 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ADan/+</sup></italic>
###xml 799 800 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1152 1157 1116 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
The occurrence of homologous recombination was confirmed by sequencing the PCR products and by performing Southern blot analysis (Fig. 1c). DNA derived from individual BRI2tADan/+ ES clones was digested with BamHI, gel separated, blotted into a nylon membrane and hybridized with either the 5' or the 3'probe. The 5' probe hybridizes with a approximately11.9 kb fragment derived from the wild-type locus. Homologous recombination at the 5' homologous region yields a approximately8.9 kb fragment upon BamHI digestion due to the introduction of the BamHI site and the PGK-neo selection cassette. ES clones BRI2ADan/+344 and BRI2ADan/+339 carry a wild type allele (11.9 kb) and a recombined allele (8.9 kb). Of note, the 11.9 kb and 8.9 kb bands had a similar intensity, indicating that 50% of the BRI2 alleles are wild type and 50% are recombined, and proving that the ES cells we have selected are a clonal populations. Similar results were obtained when homologous recombination at the 3' site was assessed. In this case the 3' probe detected a wild-type approximately11.9 kb fragment and a recombinant 4.7 kb fragment, due to the introduction of the BamHI site.
###end p 89
###begin p 90
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 444 445 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 445 452 445 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/wt</sup>
###xml 445 452 445 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ADan/wt</sup></italic>
###xml 620 621 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 621 629 621 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tADan/wt</sup>
###xml 621 629 621 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>tADan/wt</sup></italic>
###xml 868 870 868 870 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 648 664 <span type="species:ncbi:10678">bacteriophage P1</span>
###xml 844 849 <span type="species:ncbi:10090">mouse</span>
These two Danish ES cell clones (129, agouti coat colour), carrying the correct site-specific homologous recombination, were injected into C57BL/6J blastocysts (black coat colour) at the Albert Einstein College of Medicine gene-targeting facility. The resulting chimeras with a high proportion of agouti coat colour (i.e. with a high relative contribution from the injected ES cells) were backcrossed to C57BL/6J mice to obtain heterozygous BRI2ADan/wt, which were identified by PCR and Southern analysis as described above (not shown) using tail DNA. Heterozygous mice were crossed to Meu40-Cre mice to obtain Meu40/BRI2tADan/wt animals. Cre is a bacteriophage P1-encoded recombinase that catalyzes site-specific recombination between two 34 bp loxP recognition sites, resulting in the excision of the intervening DNA sequences. The resulting mouse has been named FDDKI.
###end p 90
###begin title 91
###xml 48 50 48 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
General Characteristics and Pathology of the FDDKI Mice
###end title 91
###begin p 92
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice presented with no growth abnormalities, thrived at appropriate age, as their wild type littermates. Up to age 18 months, no susceptibility to infections was noted. The animals are active and alert.
###end p 92
###begin p 93
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
Before the pathology examination, at 18 months of age, they presented in good body condition with adequate body fat, with no discharges or secretions from nostrils, conjunctiva, aural, urogenital or anal openings. Some mice also presented heart valve melanosis, which is a common finding in aged mice of various strains. Other sporadic findings, which are common in aged mice, were small foci of hepatocellular necrosis, vacuolation of and degeneration/regeneration of kidney tubular epithelial cells, mineralization in the kidney tubules in the pelvis and cortico-medullary junction (not shown). Overall, these mice have lesions that are commonly found in older mice and are considered age-related, spontaneous lesions. All of the lesions found were considered to be within the normal limits for age-related lesions. One of the animals presented with a uterine histiocytic sarcoma and hydronephrosis, both of which are found in older, untreated mice at low incidence.
###end p 93
###begin title 94
Neuropathology
###end title 94
###begin p 95
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g002">Fig. 2d</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g002">Fig. 2a</xref>
###xml 873 882 873 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g002">Fig. 2a&#8211;e</xref>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
A few animals presented a small amount of dark basophilic material deposited on either side of the lateral thalamus consistent with mineralization (incidental, Fig. 2d), which is a common finding in aged mice of various strains, and the deposits develop along the basement membranes of the vasculature and may contain calcium and phosphorus. The finding of dark brown pigment along the meninges of the olfactory bulbs is consistent with melanosis (incidental, Fig. 2a), which is also a common finding in mice in dark pigment mouse strains such as C57BL/6 or having that strain the their background. All the brain tissue and the spinal cord were stained with Congo red for potential amyloid deposition. All of the stained tissue was negative for amyloid (not shown). Samples of H&E staining of cerebral cortex, hippocampus, cerebellum, thalamus and spinal cord are shown in Fig. 2a-e.
###end p 95
###begin title 96
General Neuropatholgy.
###end title 96
###begin p 97
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
H&E staining of 18 month old FDDKI mice showing signs of melanosis in the meninges of olfactory bulb (a) and signs of mineralization in the thalamus (d). The remaining parenchyma of brain cortex and hippocampus (b), cerebellum (c) and spinal cord (e) show normal cellular structures.
###end p 97
###begin p 98
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub></italic>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 356 363 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g003">Fig. 3c</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g004">4a</xref>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g003">Fig. 3a</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g004">4d</xref>
###xml 597 607 597 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g003">Fig. 3b, d</xref>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g004">Fig. 4b</xref>
###xml 962 969 962 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g004">Fig. 4e</xref>
###xml 997 1004 997 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g004">Fig. 4b</xref>
###xml 1104 1108 1104 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 1110 1117 1110 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g004">Fig. 4f</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 269 274 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1211 1215 <span type="species:ncbi:10090">mice</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
###xml 1341 1345 <span type="species:ncbi:10090">mice</span>
Brain sections of 18-month-old mice were examined for FDD-related pathology, particularly for amyloid deposition in brain parenchyma and vessel walls. For comparison, we included sections of an age-matched female FDD-Tg mouse, which expresses the Danish mutant form of human BRI2 under the mouse prion protein promoter [20]. H&E staining of Knock In mice (Fig. 3c, 4a) showed no significant loss of neurons or noticeable malformations, and this observation was further confirmed when mutant sections were compared with those of wild type littermates (Fig. 3a, 4d). Immunostaining using anti-GFAP (Fig. 3b, d) and anti-ubiquitin (not shown) antibodies did not reveal significant differences with wild type mice in levels of activated astrocytes or presence of ubiquitinated material, respectively. Staining using Congo red or ThS did not show the presence of amyloid deposits (Fig. 4b). Amyloid deposition in FDD-Tg mice is particularly strong in the cerebellum (Fig. 4e) but not in Knock In mice (Fig. 4b) and only FDD-Tg mice showed immunoreactivity using Ab 1700, specific for the ADan amyloid peptide [20] (Fig. 4f versus 4c). Immunoreactivity was not seen in non-transgenic littermates, FDD-Tg and Knock In mice using antibody 4G8 (not shown). These results indicated that the brain of Knock In mice maintained normal morphology of aged mice and were free of amyloid deposits at 18 months of age.
###end p 98
###begin title 99
###xml 34 36 34 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Sections of the hippocampus of FDDKI mice.
###end title 99
###begin p 100
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
Sections from a wild type (a, b) and a homozygous knock-in mouse (c, d) were stained with H&E (a, c). Sections were also studied by immunohistochemistry using anti-GFAP (b, d). No significant differences were observed between wild-type and Knock In mice. Scale bars: a-d, 200 microm.
###end p 100
###begin title 101
###xml 33 35 33 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Sections of the cerebellum of FDDKI mice.
###end title 101
###begin p 102
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
Sections from a wild-type (d), homozygous knock-in mouse (a-c), and FDD-Tg mouse (e, f) were stained with H&E (a) and ThS (b, d, e). Sections were also studied by immunohistochemistry using Ab 1700, specific for the ADan amyloid peptide (c, f). No significant differences were observed between wild-type and knock-in mice. Staining with ThS and Ab 1700 shows the presence of ADan amyloid only in FDD-Tg mice (e-f). Scale bars: a-e, 100 microm; f, 200 microm.
###end p 102
###begin title 103
###xml 27 33 27 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
Biochemical Analysis of BRI2-ADan Expression
###end title 103
###begin p 104
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 122 123 122 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 123 130 123 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/wt</sup>
###xml 119 130 119 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/wt</sup></italic>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 139 148 139 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/ADan</sup>
###xml 135 148 135 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/ADan</sup></italic>
###xml 359 360 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 366 367 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 393 394 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 592 593 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 593 600 581 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/wt</sup>
###xml 589 600 577 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/wt</sup></italic>
###xml 623 624 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 624 633 612 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/ADan</sup>
###xml 620 633 608 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/ADan</sup></italic>
###xml 694 695 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 712 713 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 751 752 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 752 761 740 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/ADan</sup>
###xml 748 761 736 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/ADan</sup></italic>
###xml 828 829 816 817 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 870 871 858 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 871 878 859 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/wt</sup>
###xml 867 878 855 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/wt</sup></italic>
###xml 909 910 897 898 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 945 946 933 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 951 957 939 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
###xml 976 977 964 965 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1029 1030 1017 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1037 1038 1025 1026 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1065 1071 1053 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
###xml 1107 1108 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1108 1117 1096 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADan/ADan</sup>
###xml 1104 1117 1092 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRI<sub>2</sub><sup>ADan/ADan</sup></italic>
###xml 1127 1135 1115 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g005">Figure 5</xref>
###xml 1362 1368 1350 1356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
###xml 1456 1458 1444 1446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 1472 1491 1460 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007900-g005">Fig. 5, lower panel</xref>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 1019 1025 <span type="species:ncbi:10090">murine</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
To determine whether the mutant proteins are expressed in vivo, we made protein extracts form neuronal cultures of wt, BRI2ADan/wt and BRI2ADan/ADan mice. Western blot analysis of these samples shows three phenomenona. 1) A common, major band of about 32 kDa is readily visible in all three samples. This band corresponds to the post-furin cleavage mature BRI2 (mBRI2) polypeptide because mBRI2 is identical regardless of whether it is derived from the wild type or the mutant precursor protein. 2) A much less abundant protein of approximately33 kDa which is visible in the wild type and BRI2ADan/wt sample but not the BRI2ADan/ADan lysate. This band corresponds to the wild type, immature BRI2 precursor (imBRI2). The absence of this band in the BRI2ADan/ADan neurons is attributable to the fact that these cells have both BRI2 alleles mutated. 3) As expected, the BRI2ADan/wt sample expresses all three BRI2 polypeptides, i.e. wild type imBRI2, BRI2-ADan precursor and mBRI2. It is worth noting that, while immature murine BRI2 (imBRI2) is barely detectable, BRI2-ADan is more markedly expressed (see BRI2ADan/ADan neurons, Figure 5) in this specific experiment. Whether this is related to the artificial absence of the wild type protein (this does not happen in FDD since the patience have only one mutated allele) or reflects some interesting biology of BRI2-ADan, remains to be determined. Notably, APP expression and maturation are comparable in FDDKI and wt mice (Fig. 5, lower panel).
###end p 104
###begin title 105
###xml 27 33 27 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
Biochemical analysis of BRI2-ADan.
###end title 105
###begin p 106
###xml 167 173 167 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2-ADan</sub>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Lysates from E16-17 neuronal cultures of wt, ADan +/- and ADan +/+ mice were blotted with antibodies against BRI2 and APP. Upper panel shows impaired maturation of BRI2-ADan compared to wild type; lower panel show normal pattern of expression and maturation of APP.
###end p 106
###begin title 107
Discussion
###end title 107
###begin p 108
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-LaFerla1">[25]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-McGowan1">[26]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Price1">[27]</xref>
###xml 1796 1800 1796 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Vidal4">[20]</xref>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 624 629 <span type="species:ncbi:9606">human</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1280 1285 <span type="species:ncbi:9606">human</span>
###xml 1382 1387 <span type="species:ncbi:9606">human</span>
###xml 1416 1421 <span type="species:ncbi:10090">mouse</span>
###xml 1449 1454 <span type="species:ncbi:10090">mouse</span>
###xml 1486 1491 <span type="species:ncbi:9606">human</span>
###xml 1588 1593 <span type="species:ncbi:10090">mouse</span>
In this manuscript we present an initial characterization of a Knock In model for a human neurodegenerative disorder, FDD. This Knock In model is strategically different from the conventional genetic approach to cerebral amyloidosis. Traditionally, mouse models for human dementias are based on a transgenic approach in which human mutant proteins that cause familial forms of dementia are over-expressed under the control of brain-specific promoters [25], [26], [27]. This approach has both limitations and advantages. The potential limitations are linked to the fact that these models are genetically incongruous with the human diseases. These dementias have an autosomal dominant way of transmission and affected subjects have a wild type and a mutant allele. On the contrary, the commonly used animal models over-express, from an artificial promoter, several copies of a mini-gene coding the mutant protein. The mutant gene is therefore expressed in a spatio-temporal manner different from the natural alleles and in cells with two copies of wild type alleles. However, transgenic approaches have successfully reproduced cerebral amyloidosis in mice, and the reproduction of those lesions is one of the main parameters used to endorse an animal model as representative of the human disease. The opposite is true for a Knock In approach. In this genetic paradigm, the pathogenic human mutation is inserted in the mouse allele. Thus, the Knock In mouse is genetically faithful to the human pathology. However, the Knock In model may not successfully reproduce the amyloid lesion in the mouse. The model that we present here is a clear demonstration of the above-mentioned assumptions. A comparison of the FDD-KI model that we have created with the FDD transgenic model generated by Vidal et al [20] illustrates the superior power of a transgenic approach as far as the reproduction of amyloidogenic lesions are concerned.
###end p 108
###begin p 109
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Bentahir1">[28]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-DeStrooper1">[29]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Wolfe1">[30]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Shen1">[31]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007900-Saura1">[32]</xref>
###xml 1164 1166 1164 1166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 1299 1301 1299 1301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 1496 1498 1496 1498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KI</sub>
###xml 1572 1573 1572 1573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1582 1589 1582 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1652 1653 1652 1653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1672 1679 1672 1679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 89 94 <span type="species:ncbi:9606">Human</span>
###xml 1167 1171 <span type="species:ncbi:10090">mice</span>
###xml 1240 1245 <span type="species:ncbi:10090">mouse</span>
###xml 1302 1307 <span type="species:ncbi:10090">mouse</span>
###xml 1499 1504 <span type="species:ncbi:10090">mouse</span>
In spite of this limitation, we believe that there is some merit to a Knock In approach. Human familial dementias may have a pathogenic component due to loss of function caused by the mutation [28], [29], [30], [31], [32]. This component may participate to the pathogenic process together with a gain of toxic function due to amyloidosis. A loss of function phenotype would be hidden by a transgenic approach for two reasons: 1) the two endogenous wild type alleles can support synthesis of sufficient amounts of functional wild type protein: 2) the over-expression of a partial loss of function mutant protein may augment rather then decrease that function, as may happen in the disease. It would be erroneous to assume that the absence of obvious neuropathological lesions (such as plaques, NFTs and/or neuronal cell loss) indicate absence of clinical pathology. Functional deficits may underlie the very first clinical manifestations of neurodegenerative diseases, and memory deficits may be caused not by gross anatomical changes but by subtle dysfunctions of the neuronal network. In this framework, determining the absence of neuropathological lesions in FDDKI mice is intrinsically important. The behavioral characterization of this mouse model will test this hypothesis. In addition, the FDDKI mouse will be useful to clarify the change of trafficking or processing of Danish mutant of BRI2 protein without potential artifacts due to over-expression in transgenic models. Finally, the FDDKI mouse will be instrumental in studying the interaction between mutant BRI2 and APP in vivo and how the Danish mutation affects the inhibitory role of BRI2 on APP processing in vivo.
###end p 109
###begin p 110
###xml 83 87 <span type="species:ncbi:10090">mice</span>
We thank Erhan Ma for the help in the genotyping and PCR procedures on the ADan KI mice; we thank Dr. Susan Newbigging MSc, DVM, DVSc at the Toronto Centre for Phenogenomics, 25 Orde Street, Toronto ON M5T 3H7; we thank Dr. Bernardino Ghetti for the helpful discussion.
###end p 110
###begin title 111
References
###end title 111
###begin article-title 112
Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins.
###end article-title 112
###begin article-title 113
A stop-codon mutation in the BRI gene associated with familial British dementia.
###end article-title 113
###begin article-title 114
A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.
###end article-title 114
###begin article-title 115
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia.
###end article-title 115
###begin article-title 116
BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate.
###end article-title 116
###begin article-title 117
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.
###end article-title 117
###begin article-title 118
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production.
###end article-title 118
###begin article-title 119
Genomic organization and chromosomal localization of the Itm2a gene.
###end article-title 119
###begin article-title 120
###xml 53 58 <span type="species:ncbi:9606">Human</span>
Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family.
###end article-title 120
###begin article-title 121
BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer.
###end article-title 121
###begin article-title 122
Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation.
###end article-title 122
###begin article-title 123
Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta.
###end article-title 123
###begin article-title 124
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.
###end article-title 124
###begin article-title 125
Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease.
###end article-title 125
###begin article-title 126
Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques.
###end article-title 126
###begin article-title 127
Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles.
###end article-title 127
###begin article-title 128
BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2.
###end article-title 128
###begin article-title 129
BRI2 (ITM2b) inhibits Abeta deposition in vivo.
###end article-title 129
###begin article-title 130
###xml 38 53 <span type="species:ncbi:10090">transgenic mice</span>
Modeling familial British dementia in transgenic mice.
###end article-title 130
###begin article-title 131
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2.
###end article-title 131
###begin article-title 132
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice cloned from embryonic stem cells.
###end article-title 132
###begin article-title 133
Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role.
###end article-title 133
###begin article-title 134
Mutant presenilin 1 increases the expression and activity of BACE1.
###end article-title 134
###begin article-title 135
###xml 96 101 <span type="species:ncbi:9606">human</span>
Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain.
###end article-title 135
###begin article-title 136
Alzheimer's disease: Abeta, tau and synaptic dysfunction.
###end article-title 136
###begin article-title 137
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
A decade of modeling Alzheimer's disease in transgenic mice.
###end article-title 137
###begin article-title 138
The value of transgenic models for the study of neurodegenerative diseases.
###end article-title 138
###begin article-title 139
Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
###end article-title 139
###begin article-title 140
Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.
###end article-title 140
###begin article-title 141
When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease.
###end article-title 141
###begin article-title 142
The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.
###end article-title 142
###begin article-title 143
Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration.
###end article-title 143
###begin p 144
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
Competing Interests: LG and LD are inventors of an AECOM patent on the FDD mice. The mice discussed in this paper (BRI2-ADan knock-in mice) are patent-pending. The assign is the Albert Einstein College of Medicine. The Albert Einstein College of Medicine has licensed the patent to a Biotech company (Remegenix) of which Dr. D'Adamio is a co-founder. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors .
###end p 144
###begin p 145
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by Alzheimer Disease Research Grant A2003-076 (LD); National Institutes of Health Grants RO1 AG22024 (LD); RO1 AG21588 (LD); R21 AG027139 (LD); American Health Assistance Foundation A2008-304 (RV).
###end p 145

